Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort

Carcinogenesis

Volumn 32, Issue 6, 2011, Pages 876-881

  Chao, Li Ting ^a   Wu, Chih Feng ^a   Sung, Feng Yu ^a   Lin, Chih Lin ^b   Liu, Chun Jen ^c   Huang, Chi Jung ^a   Tsai, Keh Sung ^d   Yu, Ming Whei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c Division of Gastroenterology   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RISK; DIET RESTRICTION; ECHOGRAPHY; FOLLOW UP; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS B VIRUS; HUMAN; INSULIN BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; VIRUS CARRIER; VIRUS LOAD;

EID: 79958225945     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr058     Document Type: Article

References (41)

1. Kao,J.H. et al. (2002) Global control of hepatitis B virus infection. Lancet Infect. Dis., 2, 395-403.
2. Chen,Y.C. et al. (2010) Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology, 51, 435-444.
3. Yu,M.W. et al. (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J. Natl Cancer Inst., 97, 265-72.
4. Chan,H.L. et al. (2008) High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J. Clin. Oncol., 6, 177-182.
5. Wu,C.F. et al. (2008) Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis, 29, 106-12.
6. Sung,F.Y. et al. (2009) Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression. Gastroenterology, 37, 1687-1697.
7. Chou,Y.C. et al. (2008) Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular arcinoma. Gut, 57, 91-97.
8. Yuen,M.F. et al. (2009) Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J. Hepatol., 50, 0-88.
9. Becker,U. et al. (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology, 23, 1025-1029.
10. Hossain,P. et al. (2007) Obesity and diabetes in the developing worlda growing challenge. N. Engl. J. Med., 356, 213-215.
11. Farrell,G.C. et al. (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 43 (2 suppl. 1), S99-S112.
12. Yu,M.W. et al. (2008) Body-mass index and progression of hepatitis B: a population-based cohort study in men. J. Clin. Oncol., 26, 5576-5582.
13. Larsson,S.C. et al. (2007) Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br. J. Cancer, 97, 1005-1008.
14. Wong,G.L. et al. (2009) Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut, 58, 111-117.
15. Moucari,R. et al. (2008) Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology, 134, 416-423.
16. Cua,I.H. et al. (2008) Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology, 48, 723-731.
17. Ogunleye,A.A. et al. (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br. J. Cancer, 101, 1199-1201.
18. El-Serag,H.B. et al. (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology, 126, 460-468.
19. Adami,H.O. et al. (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J. Natl Cancer Inst., 88, 1472-1477.
20. Wideroff,L. et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J. Natl Cancer Inst., 89, 360-1365.
21. Stocks,T. et al. (2009) Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (Me-Can): analysis of six prospective ohorts. PLoS Med., 6, e1000201.
22. Wang,C.S. et al. (2009) The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol. Biomarkers Prev., 18, 2054-2060.
23. Lai,M.S. et al. (2006) Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology, 43, 1295-302.
24. Jee,S.H. et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA, 293, 194-202.
25. Matthews,D.R. et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in an. Diabetologia, 28, 412-419.
26. Stolzenberg-Solomon,R.Z. et al. (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA, 294, 2872-2878.
27. Albanes,D. et al. (2009) Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J. Natl Cancer Inst., 101, 1272-1279.
28. Therneau,T.M. et al. (1999) Computing the Cox model for case cohort designs. Lifetime Data Anal., 5, 99-112.
29. Haslam,D.W. et al. (2005) Obesity. Lancet, 366, 1197-1209.
30. Mellen,J.S. et al. (2010) The clinical presentation of chronic hepatitis B virus (HBV) infection in Asian Americans: a single center retrospective study. J. Clin. Gastroenterol., 44, 364-370.
31. Peng,D. et al. (2008) Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J. Gastroenterol. Hepatol., 3, 1082-1088(7 Pt 1).
32. Angulo,P. (2002) Nonalcoholic fatty liver disease. N. Engl. J. Med., 346, 1221-1231.
33. Giovannucci,E. (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr., 131 (suppl. 11), 3109S-3120S.
34. Chappell,J. et al. (2001) Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J. Biol. Chem., 276, 8023-38028.
35. Shafie,S.M. et al. (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. Natl Cancer Inst., 67, 51-56.
36. Gunter,M.J. et al. (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res., 68, 29-337.
37. Gunter,M.J. et al. (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 101, 48-60.
38. Yu,M.W. et al. (1997) Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am. J. Epidemiol., 45, 1039-1047.
39. Stuver,S.O. et al. (2000) Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int. J. Cancer, 87, 118-121.
40. Liaw,Y.F. et al. (2005) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int., 25, 472-489.
41. Kumar,M. et al. (2008) Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology, 134, 1376-1384.